Michael Kulke
Heidelberg Pharma (Germany)(DE)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Toxin Mechanisms and Immunotoxins, Neuroendocrine Tumor Research Advances, Silymarin and Mushroom Poisoning, Glycosylation and Glycoproteins Research
Most-Cited Works
- → Titin Isoform Switch in Ischemic Human Heart Disease(2002)378 cited
- → Passive Stiffness Changes Caused by Upregulation of Compliant Titin Isoforms in Human Dilated Cardiomyopathy Hearts(2004)331 cited
- → CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma(2016)226 cited
- → Unfolding of Titin Domains Explains the Viscoelastic Behavior of Skeletal Myofibrils(2001)207 cited
- → PEVK Domain of Titin: An Entropic Spring with Actin-Binding Properties(2002)202 cited
- → Interaction Between PEVK-Titin and Actin Filaments(2001)167 cited
- → Damped elastic recoil of the titin spring in myofibrils of human myocardium(2003)124 cited
- → Kettin, a major source of myofibrillar stiffness in Drosophila indirect flight muscle(2001)90 cited
- → HDP-101, an Anti-BCMA Antibody–Drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma Cells(2020)72 cited
- → Antibody–Drug Conjugate Payloads(2013)69 cited